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Abstract Glossopharyngeal neuralgia is a rare condition
with neuralgic sharp pain in the pharyngeal and auricular
region. Classical glossopharyngeal neuralgia is caused by
neurovascular compression at the root entry zone of the
nerve. Regarding the rare occurrence of glossopharyngeal
neuralgia, we report clinical data and magnetic resonance
imaging (MRI) ﬁndings in a case series of 19 patients, of
whom 18 underwent surgery. Two patients additionally
suffered from trigeminal neuralgia and three from addi-
tional symptomatic vagal nerve compression. In all
patients, ipsilateral neurovascular compression syndrome
of the IX cranial nerve could be shown by high-resolution
MRI and image processing, which was conﬁrmed intra-
operatively. Additional neurovascular compression of the
V cranial nerve was shown in patients suffering from tri-
geminal neuralgia. Vagal nerve neurovascular compression
could be seen in all patients during surgery. Sixteen
patients were completely pain free after surgery without
need of anticonvulsant treatment. As a consequence of the
operation, two patients suffered from transient cerebro-
spinal ﬂuid hypersecretion as a reaction to Teﬂon implants.
One patient suffered postoperatively from deep vein
thrombosis and pulmonary embolism. Six patients showed
transient cranial nerve dysfunctions (difﬁculties in swal-
lowing, vocal cord paresis), but all recovered within
1 week. One patient complained of a gnawing and burning
pain in the cervical area. Microvascular decompression is a
second-line treatment after failure of standard medical
treatment with high success in glossopharyngeal neuralgia.
High-resolution MRI and 3D visualization of the brainstem
and accompanying vessels as well as the cranial nerves is
helpful in identifying neurovascular compression before
microvascular decompression procedure.
Keywords Glossopharyngeal neuralgia  Neurovascular
compression  Microvascular decompression
Introduction
Glossopharyngeal neuralgia is a rare entity with a reported
incidence of 0.2–0.7/100,000/year. Epidemiological data
are based on the extrapolation of few data from one center
and recently from the analysis of a medical record database
[1–4]. The frequency of glossopharyngeal neuralgia is
underestimated. This is due to difﬁculties in clinical diag-
nosis, differentiation from trigeminal neuralgia and
unawareness of the disease. Glossopharyngeal neuralgia
shares several characteristics with trigeminal neuralgia:
(a) paroxysmal attacks of brief electric shock-like stabbing
pain, (b) trigger mechanisms, e.g., speaking, swallowing,
eating, breathing, cold air and slight touch of the mouth and
pharyngeal region, (c) initially good response to carbam-
azepine, and (d) association with neurovascular compres-
sion. Neurovascular compression as a source of irritation of
cranial nerves was discussed ﬁrst in 1929 by Dandy [5].
Jannetta’s operative work [12] [e.g., microvascular
decompression (MVD)] provided evidence for this
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DOI 10.1007/s10194-011-0349-xconcept. The International Classiﬁcation of Headache
Disorders (ICHD) distinguishes between classical (ICHD-
II 13.2.1) and symptomatic glossopharyngeal neuralgia
(ICHD-II 13.2.2) [6]. However, based only on clinical
ﬁndings a discrimination of both variants is not possible.
‘‘Idiopathic’’ cranial nerve neuralgias are mostly attributed
to a neurovascular nerve compression syndrome at the root
entry zone of the respective cranial nerve. The primary
goal of diagnostic procedures is to rule out symptomatic
glossopharyngeal neuralgia. Pain attacks in glossopharyn-
geal neuralgia are short (just for seconds), severe and
stabbing in the pharyngeal region, including the tonsilar
fossa, base of the tongue and below the angle of the jaw.
The pain can also be felt in the areas innervated by the
auricular and pharyngeal branches of the vagus nerve.
Some authors propose distinguishing between a pharyn-
geal, otalgic and a vagal subtype of neuralgia and therefore
suggest the term ‘‘vagoglossopharyngeal’’ neuralgia [7, 8].
A coincidence of trigeminal neuralgia and glossopha-
ryngeal neuralgia in the same patient complicates the
clinical diagnosis. However, pain attacks do not occur
simultaneously in both areas [7]. Due to the rare occur-
rence of glossopharyngeal neuralgia, we report a case
series of 19 patients to describe the clinical presentation,
imaging ﬁndings and response to medical and neurosurgi-
cal treatment in detail.
Methods
We report a series of 19 consecutive patients suffering
from glossopharyngeal neuralgia referred for surgery due
to unsatisfying response to previous medical treatment. The
clinical appearance, pain localization, medical treatment
and course of the disease were analyzed. The clinical
symptoms were classiﬁed into pharyngeal, otalgic and
vagal manifestation type of glossopharyngeal neuralgia.
Data collection was done by retrospective analysis of the
patients’ medical records. All patients were treated
between 1994 and 2009 in the Department of Neurosurgery
of the University of Erlangen-Nuremberg, Germany.
Detailed prior history and clinical examination with special
attention to cranial nerve function was done in all patients.
All patients underwent high-resolution magnetic resonance
imaging (MRI) and 3D visualization of the brainstem and
accompanying vessels and cranial nerves in this region as
described by Naraghi and Hastreiter [9–11]. Clinical data
were correlated with MRI ﬁndings. The outcome and
complications of 18 neurosurgically treated (MVD)
patients were analyzed. For operative procedures, patients
were placed in a semi-sitting position on the operating
table; monitoring including precordial transthoracic echo-
cardiography and somatosensory potentials was done, and
a retrosigmoidal craniotomy was performed with extension
to the foramen magnum. After incision of the dura, cere-
brospinal ﬂuid (CSF) was gathered from the cerebello-
pontine cistern (cisterna magna) and the cerebellar
hemisphere. The inferior and biventral lobe was smoothly
retracted to approach the lateral cerebellopontine cistern.
The IX and X nerve were accessed at their exit zone from
the brainstem and the conﬂicting vessel was identiﬁed.
Dissection of the vessel was done according to the tri-
geminal nerve decompression suggested by Jannetta [12].
A Teﬂon interpositum was chosen to keep the vessel off
[12].
All statistical analyses were performed with PASW
Statistics 18.0.0. The demographic data of men and women
were compared using t test analysis.
Results
Clinical picture and course of disease
Eleven men and eight women were investigated (Table 1).
Mean age at onset of disease was 48.5 years [range 26–83,
women (mean) 48.4 years, men (mean) 48.6 years]. Age at
the time of MVD in the 18 operated patients was 54.5 years
(mean). No signiﬁcant difference was found between men
and woman concerning either age of onset or age at the
time of MVD. Twelve patients were affected on the left
side and seven on the right side (1.7:1). Mean duration of
disease before MVD was performed in 18 of the 19 patients
was 6.5 (range 1–20) years. All 19 patients showed a
pharyngeal pain manifestation. In addition, 12 patients
showed symptoms of the otalgic type and three showed
vagal-type symptoms (cough and raucousness accompa-
nying the pain attacks, laryngeal pain attack localization).
In two patients, additional trigeminal neuralgia was diag-
nosed. One of these had undergone MVD for trigeminal
neuralgia on both sides previously (no. 17). Following the
ICHD-II-criteria, classical glossopharyngeal neuralgia was
diagnosed in 18 patients, one patient (no. 11) showed
diminished sensibility in the palatine and pharyngeal area,
but no other pathology than a neurovascular compression
syndrome was diagnosed. In this patient, there was no other
evidence of a symptomatic manifestation. In one patient,
hearing loss and diminished sensibility in the trigeminal
area was found, but these could be explained by previous
thermocoagulation and a ﬁrst MVD procedure in the past
(no. 10). Patients with symptomatic glossopharyngeal
neuralgia due to intracranial mass (tumor) or inﬂammation
were excluded from our series. Medical treatment with
anticonvulsants was used in all patients (mostly carbam-
azepine). All patients were treated with an adequate dose
regime for several years. Failure to medical treatment was
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123shown by all patients except one. By the time of evaluation
for neurosurgical treatment, one patient (no. 1) was nearly
free of symptoms under medical treatment with carbam-
azepine. Therefore, he did not undergo operation.
MRI ﬁndings
All patients underwent high-resolution MRI, and the data
were subjected to image processing and 3D visualization
(illustrated in patient no 16) (Figs. 1, 2). Data were ana-
lyzed with 3D visualization revealing a neurovascular
compression syndrome of the glossopharyngeal nerve in all
patients, ipsilateral to the pain manifestation. In addition,
MRI showed ipsilateral neurovascular compression of the
vagal nerve in all patients. In two patients, additional
ipsilateral neurovascular compression of the trigeminal
nerve could be shown. Vessels, which were assumed to
cause nerve compression, are listed for every patient
(Table 1). Nerve compression by the posterior inferior
cerebellar artery (PICA) was found in 15 patients, by the
vertebral artery and PICA in three patients, and the verte-
bral artery plus the anterior inferior cerebellar artery
(AICA) in another patient.
Outcome of MVD
Of the 18 patients, 16 who underwent microsurgical
decompression of the glossopharyngeal nerve were com-
pletely pain free after the procedure. They no longer
needed any anticonvulsant or other pain medication. One
patient (no. 4) improved substantially and medication
could be reduced (she currently only takes gabapentin).
One patient (no. 5) was pain free for 2 years, and then
neuralgia returned. After a second MVD she was sus-
tained pain free.
Complications of MVD
Two patients (nos. 3 and 4) suffered from transient CSF
hypersecretion as a reaction to the Teﬂon implant. CSF
examination revealed lymphocytic pleocytosis. No causa-
tive bacteria could be found in CSF. Antibiotics were
administered while CSF samples were taken repeatedly.
Symptoms regressed within a few days. One patient (no. 3)
suffered from postoperative deep vein thrombosis and
pulmonary embolism, which prompted oral anticoagula-
tion. Six patients showed transient cranial nerve dysfunc-
tions with difﬁculties in swallowing or vocal cord paresis,
but in all cases dysfunction resolved within 1 week. One
patient (no. 3) complained of a gnawing and burning pain
in the cervical area, but no signs of cranial nerve dys-
function were found on physical examination. Pre-existing
disturbance in sensitivity in the trigeminal area of the face
subsisted after surgical intervention. No patient suffered
any hearing reduction as a result of surgery.
Discussion
This case series focuses on symptomatology and response
to medical and surgical treatment in patients suffering from
glossopharyngeal neuralgia. Diagnosis should be consid-
ered if neuralgic pain occurs in the pharyngeal region or in
the auditory canal. The coincidence of trigeminal and
glossopharyngeal neuralgia that was found in two patients
of our series (9:5%) is comparable to previous reports
[3, 13, 14]. The coincidence of neuralgias of the V and the
IX cranial nerves can be explained by the close anatomic
relationship of the brainstem area, peripheral connections
between both nerves and central convergence [7]. Neuro-
vascular compression on the vagal nerve could be shown
by MRI techniques in all of our 19 patients, but only three
showed clinical symptoms corresponding to the vagal
nerve. The infrequently clinically diagnosed coincidence of
both neuralgias in contrast to the MRI ﬁndings may be
explained by underreporting of vagal symptoms and sub-
clinical involvement, such as asymptomatic bradycardia,
which are not noticed by the patients themselves. Fur-
thermore, it may be very difﬁcult to decide whether syn-
copes in this population can be explained by vagal
affection or the wide spectrum of alternative etiologies.
The presented data support MVD on the basis of image
processing as a safe and promising second-line treatment
after failure of standard medical treatment or unacceptable
side effects of drug therapy. ICHD-II criteria (13.2.1) for
classical glossopharyngeal neuralgia require an inconspic-
uous neurological examination (criteria D) [6]. More
detailed clinical examination revealed subtle sensory deﬁ-
cit in some patients (nos. 5, 10, 11). Nevertheless, we did
not see patients with any other lesion than neurovascular
compression. This may be explained by a selection bias.
Patients who were referred to neurosurgery and who
underwent previous routine MRI, identifying symptomatic
disease, may have been treated elsewhere.
In cases of glossopharyngeal neuralgia, MRI (including
T2, T1, FLAIR) is suggested for the exclusion of symp-
tomatic forms and for a ﬁrst hint of neurovascular
compression. MR-angiography (MRA) can show the ana-
tomical relationship between cranial nerve and vessels (in
particular arteries) [13]. In case of failure of medical
therapy, or when unacceptable side effects occur, special-
ized MRI investigations including 3D constructive inter-
ference in steady state (CISS) are required. Using a
specialized computer-based analysis, neurovascular com-
pression in the root entry zone of the cranial nerve may be
visualized as it was the case in all patients of our series
J Headache Pain (2011) 12:527–534 529
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123(Fig. 1a, b) [9]. This ﬁnding is consistent with the ﬁndings
of Akimoto [8] who showed that surgical ﬁndings in
patients with trigeminal neuralgia correlate with MRI
ﬁndings in 3D reconstruction from MRI imaging.
Of the 18 patients, 16 who underwent MVD became
permanently pain free and the two remaining patients
showed pain reduction. In former studies, pain-free rates in
76% of the patients and improvement in an additional 16%
of patients were reported [15]. Long-term results of the
intervention are good; after 10 years most patients
remained pain free [14, 15]. As reported in literature, the
PICA is the most frequent causative vessel, which com-
pressed the root entry zone of the glossopharyngeal nerve
in our series. This situation could be reliably visualized in
all of the reported patients by high-resolution MRI and
MRA, followed by image processing and 3D visualization.
Accurate visualization is necessary before attempting
operative therapy.
Risks of surgery consist of the common risk of anes-
thesiology, bleeding and infection. Special risks are hear-
ing loss, hoarseness and difﬁculties in swallowing; these
symptoms are temporary in the overwhelming majority of
the patients. Teﬂon implant is a suspected cause of CSF
hypersecretion, which results in postoperative headache.
This was conﬁrmed by a clinical study showing that lumbar
puncture with drainage of 20–30 ml CSF results in sufﬁ-
cient headache relief [16]. To improve safety during the
intervention, all patients underwent continuous intraoper-
ative monitoring of the acoustic nerve and the lower cranial
nerve EMG signals also in our series. We observed one
life-threatening complication (pulmonary embolism in
patient no. 3) and one patient with a non-recurring epileptic
seizure (no. 5). All cranial nerve dysfunctions were tran-
sient (for details see Table 1). In a national registration of
US hospitals 1,326 patients with trigeminal neuralgia, 237
with hemifacial spasm and 27 with glossopharyngeal
Fig. 1 3D visualization of the neurovascular relationships in a case
with left-sided glossopharyngeal neuralgia. With the presented
method, we obtain a global overview of the neurovascular relations.
We can move the picture in any direction and detect the presence of
relevant vessels and cranial nerves and demonstrate the neurovascular
compression at the root entry zone of the cranial nerves IX and X. The
position as seen during microsurgery (compared to Fig. 2). BA basilar
artery, VA vertebral artery, PICA posterior inferior cerebellar artery,
V rigeminal nerve, VII and VIII facial and vestibulocochlear nerve, IX
glossopharyngeal nerve, X vagus nerve, NVC neurovascular
compression
Fig. 2 Intraoperative ﬁnding of the visualized case in a–c. The
vertebral artery runs from caudal to rostral, while the (a) PICA runs in
an upward loop close to the surface of the medulla and the root entry
zone of the cranial nerves IX and X (b) inducing a neurovascular
compression at this site. Adequate decompression was (c) achieved by
insertion of Teﬂon. The intraoperative ﬁndings correspond very
clearly to the results of the 3D visualization
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123neuralgia were reported. All patients were treated with
MVD (Jannetta’s procedure) [17–19]. Mortality in this
series was 0.3%; neurological deﬁcit was reported in 1.7%
of cases. The rate of adverse events depended on the fre-
quency of the intervention in the hospital.
Of the 19 patients, 6 (32%) in our study suffered from
additional arterial hypertension. Autoptic studies and
clinical observations show weak evidence of a relationship
between hypertension and neurovascular compression of
the vagal and glossopharyngeal nerves, especially if left
sided with compression of the rostral ventrolateral medulla
oblongata [20–22]. Microvascular decompression improved
arterial hypertension in some of these patients [20–22].
However, it has to be considered that hypertension is fre-
quent in a cohort with a mean age of 54.5 years. Therefore,
systematic follow-up with long-term blood pressure mea-
surement is recommended in future studies.
Conclusion
Patients suffering from uncommon facial pain syndromes
including neuralgias of the cranial nerves should be treated
in centers focusing on headaches and facial pain, if ﬁrst-
line medical treatment fails or diagnosis remains unclear.
Interdisciplinary workup of cases opens the door to suc-
cessful treatment even in difﬁcult situations. Modern
techniques of imaging such as high-resolution MRI and
subsequent image processing with 3D visualization provide
precise diagnosis of potential neurovascular compression
of various cranial nerves (especially vagal, glossopharyn-
geal and trigeminal nerves). Microvascular decompression
is a safe and successful treatment alternative in patients
with failure or several side effects of medical treatment.
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